𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritis

✍ Scribed by Tino Munster; John P. Gibbs; Danny Shen; Bruce A. Baethge; Gary R. Botstein; Jacques Caldwell; Fredrick Dietz; Robert Ettlinger; Harvey E. Golden; Herbert Lindsley; George E. McLaughlin; Larry W. Moreland; W. Neal Roberts; Theodore W. Rooney; Bruce Rothschild; Marshall Sack; Anthony I. Sebba; Michael Weisman; Kathryn E. Welch; David Yocum; Daniel E. Furst

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
363 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hydroxychloroquine use associated with i
Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients
✍ Stephanie J. Morris; Mary Chester M. Wasko; Jana L. Antohe; Jennifer A. Sartoriu 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 95 KB 👁 2 views

## Abstract ## Objective Cardiovascular disease (CVD) is the leading cause of death in patients with rheumatoid arthritis (RA). Disease‐modifying therapies that improve risk factors for CVD, such as dyslipidemia, are desired. This study used an electronic health record to determine if hydroxychlor

Development of antiinfliximab antibodies
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
✍ Gerrit Jan Wolbink; Marijn Vis; Willem Lems; Alexandre E. Voskuyl; Els De Groot; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

## Abstract ## Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This study evaluated the clinical significance of these antibodies in patients with rheumatoid arthr